Status:

SUSPENDED

Membrane Lipid Replacement in Fibromyalgia

Lead Sponsor:

Institute for Molecular Medicine

Conditions:

Fibromyalgia

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

The purpose of this study is to determine the clinical effectiveness of an all-natural, patented wafer with active ingredients that are FDA approved as Generally Recognized as Safe (GRAS) Reference: U...

Detailed Description

Adult male and female volunteers (n=60, aged 18-64) with a diagnosis of Fibromyalgia will be recruited by referral, newspapers, flyers, radio and internet ads, and asked to complete an Informed Consen...

Eligibility Criteria

Inclusion

  • You are an adult male or female (aged 18-70).
  • You have Fibromyalgia or a related clinical condition.
  • You are mobile during the day.
  • You are willing to sign an informed consent document.
  • You are willing to have 10 cc (two teaspoons) of blood drawn for analysis.
  • You are willing to take part in a clinical study that will last 14 weeks.
  • You have internet access and an email address.

Exclusion

  • You are not an adult.
  • You do not have Fibromyalgia or a related clinical condition.
  • You are not mobile, spending more than 10 hours per day in bed.
  • You are not willing and able to sign an informed consent document.
  • You are not able to be present at a test location or have a blood draw of 10 cc (2 teaspoons) for blood analysis.
  • You have unusually high or low values on your blood chemistry screen.
  • You are pregnant
  • You have been declared mentally incompetent by a qualified health care professional.
  • You have a positive diagnosis of cancer, HIV, hepatitis and other major illnesses, such as severe hypertension, neurodegenerative or autoimmune disease.
  • You on immune suppressing drugs or medications.
  • You are legally barred from signing and informed consent document.

Key Trial Info

Start Date :

May 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2023

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT03288389

Start Date

May 1 2017

End Date

June 1 2023

Last Update

April 20 2020

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Priority Health & Wellness

Pearland, Texas, United States, 77581

2

Office of Dr. Paul Breeding

San Antonio, Texas, United States, 78209

3

Blue Hole Wellness

Wimberley, Texas, United States, 78676